Variant report
Variant | nsv965549 |
---|---|
Chromosome Location | chr5:43877737-43886194 |
allele | n/a |
Outlinks | Ensembl   UCSC |
- TF binding region (count:0)
- CpG islands (count:0)
- Chromatin interactive region (count:0)
- LncRNA region (count:0)
- Mature miRNA region (count: 0)
- miRNA target sites (count:0)
No data |
No data |
No data |
No data |
No data |
No data |
No data |
No. | Variant name | Chromosome position | Chromatin state | Related regulatory elements | Target genes | Extended variants | Associated traits |
---|---|---|---|---|---|---|---|
1 | rs145179418 | chr5:43877780-43877781 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
2 | rs139008862 | chr5:43877792-43877793 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
3 | rs368304942 | chr5:43877796-43877797 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
4 | rs184454183 | chr5:43877811-43877812 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
5 | rs189605766 | chr5:43877860-43877861 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
6 | rs553080156 | chr5:43877896-43877897 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
7 | rs572987092 | chr5:43877899-43877900 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
8 | rs149469993 | chr5:43877905-43877906 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
9 | rs565134250 | chr5:43877925-43877926 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
10 | rs555866906 | chr5:43877931-43877932 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
11 | rs72762325 | chr5:43877971-43877972 | Weak transcription | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
12 | rs544897247 | chr5:43877997-43877998 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
13 | rs376645748 | chr5:43878003-43878004 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
14 | rs181968616 | chr5:43878028-43878029 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
15 | rs530520519 | chr5:43878071-43878072 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
16 | rs200758113 | chr5:43878098-43878099 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
17 | rs528903719 | chr5:43878111-43878112 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
18 | rs184569003 | chr5:43878239-43878240 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
19 | rs565811865 | chr5:43878274-43878275 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
20 | rs13159427 | chr5:43878298-43878299 | Weak transcription | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
21 | rs189008882 | chr5:43878304-43878305 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
22 | rs376102738 | chr5:43878353-43878354 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
23 | rs549104773 | chr5:43878371-43878372 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
24 | rs10061100 | chr5:43878415-43878416 | Weak transcription | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
25 | rs112508860 | chr5:43878486-43878487 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
26 | rs143846945 | chr5:43878540-43878541 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
27 | rs148222482 | chr5:43878629-43878630 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
28 | rs141184465 | chr5:43878660-43878661 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
29 | rs376906512 | chr5:43878745-43878746 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
30 | rs552939493 | chr5:43878767-43878768 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
31 | rs147373170 | chr5:43878865-43878866 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
32 | rs546046892 | chr5:43878866-43878867 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
33 | rs567138512 | chr5:43878887-43878888 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
34 | rs139701693 | chr5:43878898-43878899 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
35 | rs538749774 | chr5:43878929-43878930 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
36 | rs558739852 | chr5:43878980-43878981 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
37 | rs112425730 | chr5:43878985-43878986 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
38 | rs544449461 | chr5:43878986-43878987 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
39 | rs576413960 | chr5:43879005-43879006 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
40 | rs368965898 | chr5:43879008-43879009 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
41 | rs13184624 | chr5:43879071-43879072 | Enhancers | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
42 | rs372057270 | chr5:43879106-43879107 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
43 | rs562201821 | chr5:43879170-43879171 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
44 | rs575168256 | chr5:43879207-43879208 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
45 | rs376604896 | chr5:43879244-43879245 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
46 | rs542682114 | chr5:43879261-43879262 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
47 | rs559397189 | chr5:43879286-43879287 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
48 | rs528053249 | chr5:43879292-43879293 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
49 | rs529364679 | chr5:43879299-43879300 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
50 | rs551518401 | chr5:43879384-43879385 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
Disease | PMID | Source |
---|---|---|
Medulloblastoma | 16783165 | CNVD |
Thyroid cancer | 19087340 | CNVD |
Liposarcoma | 21253554 | CNVD |
Pancreatic endocrine tumor | 17639061 | CNVD |
Cervical Cancer | 21857958 | CNVD |
Cervical cancer | 21062161 | CNVD |
Esophageal squamous carcinoma | 21637470 | CNVD |
Ewing''s sarcoma | 21437220 | CNVD |
Glioblastoma multiforme | 19960244 | CNVD |
Glioblastoma multiforme | 21080181 | CNVD |
Oral cancer | 21386901 | CNVD |
Astrocytoma | 17387387 | CNVD |
Breast cancer | 21264507 | CNVD |
Acute lymphoblastic leukemia | 20067559 | CNVD |
Esophageal squamous carcinoma | 18350619 | CNVD |
Ewing''s sarcoma | 17952124 | CNVD |
Malignant mesothelioma | 18160781 | CNVD |
Pleural malignant mesothelioma | 18160781 | CNVD |
Cervical cancer | 18559093 | CNVD |
Basal cell lymphoma | 16317097 | CNVD |
Diffuse large b-cell lymphoma | 16317097 | CNVD |
Metanephric adenoma | 20802469 | CNVD |
Acute lymphoblastic leukemia | 17690704 | CNVD |
Gastrointestinal stromal cancer | 16982739 | CNVD |
Medulloblastoma | 21979893 | CNVD |
Phyllodes tumor | 17334353 | CNVD |
Malaria | 21533027 | CNVD |
Renal cell carcinoma | 19461508 | CNVD |
Colorectal cancer | 21645411 | CNVD |
Gastric cancer | 22152101 | CNVD |
Oesophago-gastric ulcer | 22152101 | CNVD |
Ovarian cancer | 21781307 | CNVD |
Breast cancer | 20668451 | CNVD |
Cancer | 20668451 | CNVD |
Lung cancer | 20668451 | CNVD |
Ovarian cancer | 20668451 | CNVD |
Pancreas cancer | 20668451 | CNVD |
Prostate cancer | 20668451 | CNVD |
Cancer | 20164919 | CNVD |
Acute lymphoblastic leukemia | 20435627 | CNVD |
T-cell prolymphocytic leukemia | 19278963 | CNVD |
Multiple myeloma | 17550852 | CNVD |
Thoracic aortic aneurysm | 21092924 | CNVD |
Bladder cancer | 21909424 | CNVD |
DNA damage stimulus | 22844521 | CNVD |
DNA repair | 22844521 | CNVD |
Breast cancer | 21785460 | CNVD |
Spinal muscular atrophy | 22422766 | CNVD |
Spinal muscular atrophy | 22558076 | CNVD |
Spinal muscular atrophy | 21320981 | CNVD |
Spinal muscular atrophy | 21762474 | CNVD |
Cancer | 16751803 | CNVD |
Breast cancer | 16608533 | CNVD |
Autism | 22495311 | CNVD |
Intellectual disability | 22102821 | CNVD |
Cervical squamous cell carcinoma | 21590768 | CNVD |
Prostate cancer | 21965145 | CNVD |
Cancer | 21183584 | CNVD |
Ovarian cancer | 20844748 | CNVD |
Myeloproliferative neoplasm | 20015882 | CNVD |
Breast cancer | 17603634 | CNVD |
Melanoma | 18172304 | CNVD |
Glioblastoma multiforme | 22286061 | CNVD |
Ovarian cancer | 21720365 | CNVD |
Lung cancer | 18438408 | CNVD |
Glioma | 20126413 | CNVD |
Non-small cell lung cancer | 21829676 | CNVD |
Breast cancer | 22032731 | CNVD |
Esophageal cancer | 20955586 | CNVD |
Breast cancer | 17133270 | CNVD |
Congenital anomalies of the kidney and urinary tract | 18694510 | CNVD |
Breast cancer | 17393978 | CNVD |
Pleomorphic liposarcoma | 18784837 | CNVD |
Invasive pancreatic ductal carcinoma | 16982739 | CNVD |
small cell lung cancer | 20016488 | CNVD |
Acute lymphoblastic leukemia | 21339820 | CNVD |
Acute myeloid leukemia | 20729466 | CNVD |
Ovarian clear cell carcinoma | 19293255 | CNVD |
Hirschsprung''s Disease | 21712996 | CNVD |
Breast cancer | 21364760 | CNVD |
Intellectual disability | 21811512 | CNVD |
Lung adenocarcinoma | 21935476 | CNVD |
Myelofibrosis | 22110671 | CNVD |
Intracranial aneurysm | 16715129 | CNVD |
Multiple myeloma | 16616336 | CNVD |
Cancer | 21359685 | CNVD |
adenomatous polyposis | 22470819 | CNVD |
Chronic lymphocytic leukemia | 21546498 | CNVD |
Lung cancer | 21569311 | CNVD |
No. | Chromosome Location | Chromatin state | Cell line | Tissue |
---|---|---|---|---|
1 | chr5:43875400-43878600 | Weak transcription | Fetal Lung | lung |
2 | chr5:43876200-43879000 | Weak transcription | hESC Derived CD184+ Endoderm Cultured Cells | ES cell derived |
3 | chr5:43878600-43879200 | Enhancers | Fetal Lung | lung |
4 | chr5:43879000-43879600 | Enhancers | hESC Derived CD184+ Endoderm Cultured Cells | ES cell derived |
5 | chr5:43879600-43885200 | Weak transcription | hESC Derived CD184+ Endoderm Cultured Cells | ES cell derived |
6 | chr5:43880200-43880400 | Enhancers | Fetal Heart | heart |
7 | chr5:43885200-43885600 | Enhancers | ES-I3 Cell Line | embryonic stem cell |
8 | chr5:43885200-43886800 | Enhancers | hESC Derived CD184+ Endoderm Cultured Cells | ES cell derived |